Sysmex America, a diagnostic solutions company offering hematology, urinalysis, information systems, and flow cytometry testing technology, announced its plan to sell hemostasis instruments and reagents to laboratories in the United States beginning in April, under the company’s mutual OEM agreement with Siemens Healthineers.
With regulatory activities complete, the OEM agreement allows each company to distribute hemostasis instruments (that are provided by Sysmex) and reagents (provided by Siemens) under their respective brands. Both companies say they will market their hemostasis products and services independently of each other.
“Sysmex has been innovating hemostasis analyzers for more than 30 years, offering complete, easy-to-use hemostasis solutions for laboratories of all sizes and complexities,” says Andy Hay, president and chief executive officer of Sysmex America.
Sysmex and Siemens Partnership
Since entering into a global agreement on distribution, sales, and services for hemostasis products in 1995, Sysmex and Siemens Healthineers have built a solid partnership, becoming one of the leading solution providers in the global hemostasis segment.
“A trusted reagent portfolio, coupled with the service you expect from Sysmex, ensures that the integration of hemostasis into laboratories will be a pain-free experience,” added Hay.
Further reading: Sysmex Expands Sale of Reagents for Alzheimer’s Testing to Europe
